Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis - Yahoo Finance

Roche's Gazyva Now a Breakthrough Therapy for Lupus Nephritis  Yahoo Finance

Roche's (RHHBY) lymphoma drug, Gazyva, obtains Breakthrough Therapy designation in the United States for lupus nephritis.



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases